Multi-Center,Open Label, Single Arm Study to Assess Efficacy, Safety, Bleeding Pattern and Pharmacokinetics of the Ultra Low Dose Levonorgestrel Intrauterine Contraceptive System (LCS) for a Maximum of 3 Years in Women 18 to 40 Years of Age.
Phase of Trial: Phase III
Latest Information Update: 15 Oct 2014
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms MAGIC
- Sponsors Bayer
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jul 2010 Planned end date changed from 1 May 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 30 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.